• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性化脓性胆管炎患者的胆管癌自然病程和风险:一项回顾性队列研究。

Natural Course and Risk of Cholangiocarcinoma in Patients with Recurrent Pyogenic Cholangitis: A Retrospective Cohort Study.

机构信息

Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul.

Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.

出版信息

Gut Liver. 2019 May 15;13(3):373-379. doi: 10.5009/gnl18339.

DOI:10.5009/gnl18339
PMID:30600674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6529165/
Abstract

BACKGROUND/AIMS: Recurrent pyogenic cholangitis (RPC) is a chronic progressive disease frequently accompanied by cholangiocarcinoma (CCA). This study aimed to investigate the natural course of RPC and identify factors associated with CCA.

METHODS

From January 2005 to December 2016, 310 patients diagnosed with RPC at Seoul National University Hospital were included. Complications and management during follow-up were recorded. CCA-free probability was estimated by Kaplan-Meier method, and risk factors associated with CCA were analyzed using log-rank test and Cox’s proportional hazard regression model.

RESULTS

Mean age at diagnosis was 59.1±10.9 years and mean follow-up duration was 84.0±64.1 months. An intrahepatic duct stone was found in 253 patients (81.6%). Liver atrophy was identified in 185 patients (59.7%) and most commonly located at the left lobe (65.4%). Acute cholangitis, liver abscesses, cirrhotic complications, and CCA developed in 41.3%, 19.4%, 9.7%, and 7.4%, respectively. During follow-up, complete resolution rate after hepatectomy, biliary bypass surgery, and choledocholithotomy with T-tube insertion reached 82.3%, 55.2%, and 42.1%, respectively. None of the patients who maintained complete resolution by the last follow-up day developed CCA. In univariate analysis, female, both-sided intrahepatic duct stones, and liver atrophy at any location were associated with increased risk of CCA. Multivariate analysis revealed that both-sided atrophy significantly increased risk of CCA (hazard ratio, 4.56; 95% confidence interval, 1.48 to 14.09; p=0.008). In 21 patients who developed intrahepatic CCA, tumor was located mostly in the atrophied lobe (p=0.023).

CONCLUSIONS

In RPC patients, acute cholangitis, liver abscess, cirrhotic complications, and CCA frequently developed. Both-sided liver atrophy was a significant risk factor for developing CCA.

摘要

背景/目的:复发性化脓性胆管炎(RPC)是一种慢性进行性疾病,常伴有胆管癌(CCA)。本研究旨在探讨 RPC 的自然病程,并确定与 CCA 相关的因素。

方法

本研究纳入了 2005 年 1 月至 2016 年 12 月在首尔国立大学医院诊断为 RPC 的 310 例患者。记录随访期间的并发症和治疗情况。通过 Kaplan-Meier 法估计无 CCA 生存率,采用对数秩检验和 Cox 比例风险回归模型分析与 CCA 相关的危险因素。

结果

患者的平均年龄为 59.1±10.9 岁,平均随访时间为 84.0±64.1 个月。253 例(81.6%)患者存在肝内胆管结石。185 例(59.7%)患者存在肝萎缩,最常见于左叶(65.4%)。急性胆管炎、肝脓肿、肝硬化并发症和 CCA 的发生率分别为 41.3%、19.4%、9.7%和 7.4%。随访期间,肝切除术、胆管旁路手术和经 T 管胆管取石术的完全缓解率分别达到 82.3%、55.2%和 42.1%。最后一次随访日无 CCA 患者仍保持完全缓解。单因素分析显示,女性、双侧肝内胆管结石和任何部位的肝萎缩与 CCA 风险增加相关。多因素分析显示,双侧肝萎缩显著增加 CCA 的风险(危险比,4.56;95%置信区间,1.48 至 14.09;p=0.008)。在 21 例发生肝内 CCA 的患者中,肿瘤主要位于萎缩的肝叶(p=0.023)。

结论

在 RPC 患者中,急性胆管炎、肝脓肿、肝硬化并发症和 CCA 经常发生。双侧肝萎缩是发生 CCA 的显著危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b6/6529165/c47374d57e75/gnl-13-373f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b6/6529165/b142202242a1/gnl-13-373f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b6/6529165/90ffd74ff1e0/gnl-13-373f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b6/6529165/c47374d57e75/gnl-13-373f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b6/6529165/b142202242a1/gnl-13-373f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b6/6529165/90ffd74ff1e0/gnl-13-373f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b6/6529165/c47374d57e75/gnl-13-373f3.jpg

相似文献

1
Natural Course and Risk of Cholangiocarcinoma in Patients with Recurrent Pyogenic Cholangitis: A Retrospective Cohort Study.复发性化脓性胆管炎患者的胆管癌自然病程和风险:一项回顾性队列研究。
Gut Liver. 2019 May 15;13(3):373-379. doi: 10.5009/gnl18339.
2
Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications.比较肝内胆管结石相关的并发和继发胆管癌:临床意义。
World J Gastroenterol. 2013 Jan 21;19(3):375-80. doi: 10.3748/wjg.v19.i3.375.
3
Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.炎症性肠病的病程与原发性硬化性胆管炎合并炎症性肠病患者胆管癌风险增加相关。
Am J Gastroenterol. 2016 May;111(5):705-11. doi: 10.1038/ajg.2016.55. Epub 2016 Mar 22.
4
Association of Endoscopic Sphincterotomy or Papillary Balloon Dilatation and Biliary Cancer: A Population-Based Cohort Study.内镜括约肌切开术或乳头球囊扩张术与胆管癌的关联:一项基于人群的队列研究
Medicine (Baltimore). 2015 Jun;94(23):e926. doi: 10.1097/MD.0000000000000926.
5
Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis.肝内胆管结石手术及非手术治疗后的长期疗效及复发因素评估
Surgery. 2009 Nov;146(5):843-53. doi: 10.1016/j.surg.2009.04.009. Epub 2009 Jun 28.
6
Recurrent pyogenic cholangitis - an independent poor prognostic indicator for resectable intrahepatic cholangiocarcinoma: A propensity score matched analysis.复发性化脓性胆管炎是可切除性肝内胆管细胞癌的独立不良预后指标:一项倾向评分匹配分析。
HPB (Oxford). 2018 Nov;20(11):1067-1072. doi: 10.1016/j.hpb.2018.05.006. Epub 2018 Jul 14.
7
Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones.肝内胆管结石初次肝切除术后胆管癌的危险因素
World J Surg. 2017 Mar;41(3):835-843. doi: 10.1007/s00268-016-3752-2.
8
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.原发性硬化性胆管炎的原位肝移植:单中心12年经验
Ann Surg. 1997 May;225(5):472-81; discussion 481-3. doi: 10.1097/00000658-199705000-00004.
9
CT findings of cholangiocarcinoma associated with recurrent pyogenic cholangitis.复发性化脓性胆管炎相关胆管癌的CT表现
AJR Am J Roentgenol. 2006 Dec;187(6):1571-7. doi: 10.2214/AJR.05.0486.
10
Surgical management decreases disease recurrence risk in recurrent pyogenic cholangitis.
ANZ J Surg. 2018 Sep;88(9):E659-E663. doi: 10.1111/ans.14319. Epub 2017 Dec 11.

引用本文的文献

1
Thulium laser-assisted laparoscopic management of intrahepatic stones in recurrent pyogenic cholangitis: A case report and review of minimally invasive approaches.铥激光辅助腹腔镜治疗复发性化脓性胆管炎肝内结石:一例报告及微创治疗方法综述
Int J Surg Case Rep. 2025 Mar;128:111005. doi: 10.1016/j.ijscr.2025.111005. Epub 2025 Feb 2.
2
Factors influencing recurrence and model development for recurrence of minimally invasive percutaneous transhepatic lithotripsy: a single-center retrospective study.影响微创经皮肝穿刺碎石术后复发及复发模型建立的因素:一项单中心回顾性研究
Am J Transl Res. 2024 May 15;16(5):1740-1748. doi: 10.62347/TVRY9827. eCollection 2024.
3

本文引用的文献

1
Recurrent pyogenic cholangitis: a review of imaging findings and clinical management.复发性化脓性胆管炎:影像学表现与临床处理的综述。
Abdom Radiol (NY). 2017 Jan;42(1):46-56. doi: 10.1007/s00261-016-0953-y.
2
Outcome of surgery for recurrent pyogenic cholangitis: a single center experience.复发性化脓性胆管炎的手术治疗结果:单中心经验
HPB (Oxford). 2016 Oct;18(10):821-826. doi: 10.1016/j.hpb.2016.06.001. Epub 2016 Jun 28.
3
Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis.
Hepatolithiasis: Epidemiology, presentation, classification and management of a complex disease.
肝内胆管结石:一种复杂疾病的流行病学、临床表现、分类及管理
World J Gastroenterol. 2024 Apr 7;30(13):1836-1850. doi: 10.3748/wjg.v30.i13.1836.
4
Analysis of Pathogenic Bacteria Distribution and Related Factors in Recurrent Acute Cholangitis.复发性急性胆管炎的病原菌分布及相关因素分析
Infect Drug Resist. 2023 Jul 20;16:4729-4740. doi: 10.2147/IDR.S418752. eCollection 2023.
5
Subacute liver and respiratory failure after segmental hepatectomy for complicated hepatolithiasis with secondary biliary cirrhosis: A case report.复杂肝内胆管结石伴继发性胆汁性肝硬化行肝段切除术后亚急性肝和呼吸衰竭:一例报告
World J Gastrointest Surg. 2022 Apr 27;14(4):341-351. doi: 10.4240/wjgs.v14.i4.341.
6
A rare presentation of hepatolithiasis in an adolescent patient: A case report.一名青少年患者肝内胆管结石的罕见表现:病例报告
Int J Surg Case Rep. 2020;72:343-345. doi: 10.1016/j.ijscr.2020.06.017. Epub 2020 Jun 12.
临床上令人担忧的胆管癌节段性胆管扩张:与复发性化脓性胆管炎的比较
Hum Pathol. 2015 Mar;46(3):426-33. doi: 10.1016/j.humpath.2014.11.019. Epub 2014 Dec 9.
4
Oriental cholangiohepatitis - is our surgery appropriate?东方胆管性肝炎——我们的手术方法合适吗?
Int J Surg. 2014;12(8):789-93. doi: 10.1016/j.ijsu.2014.05.078. Epub 2014 Jun 8.
5
Surgical management of recurrent pyogenic cholangitis: 10 years of experience in a tertiary referral centre in Hong Kong.复发性化脓性胆管炎的外科治疗:香港一家三级转诊中心的10年经验
HPB (Oxford). 2014 Aug;16(8):776-80. doi: 10.1111/hpb.12185. Epub 2013 Nov 7.
6
Liver masses: a clinical, radiologic, and pathologic perspective.肝脏肿物:临床、放射学及病理学视角
Clin Gastroenterol Hepatol. 2014 Sep;12(9):1414-29. doi: 10.1016/j.cgh.2013.09.017. Epub 2013 Sep 18.
7
Recurrent pyogenic cholangitis: disease characteristics and patterns of recurrence.复发性化脓性胆管炎:疾病特征与复发模式
ISRN Surg. 2013 May 25;2013:536081. doi: 10.1155/2013/536081. Print 2013.
8
Is pyogenic liver abscess associated with recurrent pyogenic cholangitis a distinct clinical entity? A retrospective analysis over a 10-year period in a regional hospital.化脓性肝脓肿与复发性化脓性胆管炎相关是否为一种独特的临床实体?一家地区医院 10 年回顾性分析。
Eur J Gastroenterol Hepatol. 2011 Sep;23(9):770-7. doi: 10.1097/MEG.0b013e328348cb9c.
9
Primary hepatolithiasis, recurrent pyogenic cholangitis, and oriental cholangiohepatitis: a tale of 3 countries.原发性肝胆管结石、复发性化脓性胆管炎和东方胆管肝炎:三国故事。
Adv Anat Pathol. 2011 Jul;18(4):318-28. doi: 10.1097/PAP.0b013e318220fb75.
10
Risk factors for cholangiocarcinoma.胆管癌的危险因素。
Hepatology. 2011 Jul;54(1):173-84. doi: 10.1002/hep.24351.